Grant: Engage Grants Program
Brock University
$25,000.00
Development of ultrafast colorimetric assays and devices for integration into the Nix Color Sensor
FY 2017-18
Summary
Point-of-care tests (POCT) are simple medical tests that can bring complex disease diagnostic and screening tests currently performed at centralized facilities to patients bedside and thus are envisioned to significantly improve the quality of healthcare. However, only a few POCT systems have been commercialized for diagnosis, prognosis, and screening of devastating diseases, such as bacteria and virus infections. This proposed research will work towards design, fabrication and testing of a smartphonebased POCT diagnostic system that detects bacterial and viral pathogens from patient samples by identifying species-specific genetic sequences using color. Leveraging the advantages of DNA-mediated ultrafast color generation and accurate color identification using the Nix Color Sensor, this system will analyze clinical sample for major infectious diseases in less than one hour by just using a smartphone and thus allow physicians to screen patients accurately in a non-invasive manner during a single visit. If successful, the simple and inexpensive smartphone-based tests, which are currently not available, can be easily incorporated into a routine physical checkup to screen patients before presentation of overt symptoms. Such early screening will hold great promise to enable personalized healthcare, improve quality of life, and decrease the financial costs associated with patient care.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
515980-2017
Name nom
Li, Feng
Department département
Chemistry
Organization id
22
Institution établissement
Brock University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Partie
1
Nb partie
1
Application title
Development of ultrafast colorimetric assays and devices for integration into the Nix Color Sensor
Keyword
NSERC
Application summary
Point-of-care tests (POCT) are simple medical tests that can bring complex disease diagnostic and screening tests currently performed at centralized facilities to patients bedside and thus are envisioned to significantly improve the quality of healthcare. However, only a few POCT systems have been commercialized for diagnosis, prognosis, and screening of devastating diseases, such as bacteria and virus infections. This proposed research will work towards design, fabrication and testing of a smartphonebased POCT diagnostic system that detects bacterial and viral pathogens from patient samples by identifying species-specific genetic sequences using color. Leveraging the advantages of DNA-mediated ultrafast color generation and accurate color identification using the Nix Color Sensor, this system will analyze clinical sample for major infectious diseases in less than one hour by just using a smartphone and thus allow physicians to screen patients accurately in a non-invasive manner during a single visit. If successful, the simple and inexpensive smartphone-based tests, which are currently not available, can be easily incorporated into a routine physical checkup to screen patients before presentation of overt symptoms. Such early screening will hold great promise to enable personalized healthcare, improve quality of life, and decrease the financial costs associated with patient care.